No Data
Sobao Protein (603231.SH): Currently, the company's protein products are not used for Medical Beauty.
On March 11, Glonghui reported that Suobao Protein (603231.SH) stated on the investor interactive platform that the company mainly engages in the research, production, and sales of Soybean protein series products. The company's Soybean protein products can be applied in areas such as plant-based meat, meat products, Snack Food, and health supplements. Currently, the company's protein products are not used in Medical Beauty.
Subao Protein (603231.SH): Currently, the sales share in the USA market is extremely low, and there are no Soybean imports from the USA.
On March 6, Glory Financial reported that Suobao Protein (603231.SH) stated on the investor interaction platform that the company's main raw material is non-Transgenic Soybean, primarily sourced from domestic suppliers. The company's current sales proportion in the USA market is extremely low, and there are no imports of Soybean from the USA, so these matters have a minimal overall impact on the company. The company will continue to monitor the progress of related matters and actively take measures to respond to potential risks.
Sobao Protein (603231.SH): There is no direct supply of protein products to large breeding companies.
On March 6, Glonghui reported that Suobao Protein (603231.SH) stated on the investor interaction platform that the company does not directly supply protein products to large-scale farming companies.
Sobao Protein (603231.SH): 58.4012 million restricted shares will be released from restriction on December 16.
Gelonghui, December 10, 2023丨Suobobao Protein (603231.SH) announced that the total number of Stocks available for circulation this time is 58.4012 million shares. The date for the Stocks to be listed and circulated is December 16, 2024.
Solbar Ningbo Protein Technology Co., Ltd.'s (SHSE:603231) Stock Is Going Strong: Have Financials A Role To Play?
Announcement of key operating data for the first three quarters of 2024
